Feedback / Questions
BA3182 - BioAtla
https://www.globenewswire.com/news-release/2025/10/20/3169303/0/en/BioAtla-Presents-Promising-Interim-Data-from-its-Phase-1-Trial-with-BA3182-in-Patients-with-Treatment-Refractory-Metastatic-Adenocarcinoma-at-ESMO-2025.html
Oct 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next